Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)

Autor: D I Stenver, H Khan, Morten Friis, Merete Lund Hetland, U Tarp, A Petri, Janne Unkerskov, A Hansen, T. Ravn, L.S. Andersen, Mikkel Østergaard

Publikováno v: Hetland, M L, Unkerskov, J, Ravn, J, Friis, M, Tarp, U, Andersen, L S, Petri, A, Khan, H, Stenver, D I, Hansen, A & Østergaard, M 2005, ' Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO) ', Scandinavian Journal of Rheumatology, vol. 34, no. 1, pp. 40-44 .

Objective: To present from the Danish Database for Biological Therapies in Rheumatology (DANBIO) the frequencies and types of adverse events as well as risk factors during treatment with biological agents in clinical practice.Methods: Adverse events

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802d13a053eb8f632dea3e80eaff3069
https://portal.findresearcher.sdu.dk/da/publications/fde2c500-e11d-11db-9628-000ea68e967b

[Erythropoietin treatment of dialysis patients]

Autor: D I, Stenver, B, Nielsen

Publikováno v: Ugeskrift for laeger. 156(17)

The effect of recombinant human erythropoietin therapy on correction of renal anaemia was evaluated. A total of 100 patients with endstage renal disease and anaemia (level of haemoglobin9.6 g/dl) received erythropoietin for 125 patient years. In 81 p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::78890c6c433af1c37610dae33a920884
https://pubmed.ncbi.nlm.nih.gov/8016967